Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

OCS-01

Phase 2Small molecule

QQuan Dong Nguyen

OCS-01 is one of 24 small molecule programs targeting Uveitis. It is currently in Phase 2.

1

Indications

3

Total Trials

1

Active Trials

23

Competitors

Pipeline

Status by Indication[3][1]

Indication

UveitisActive, not recruiting

UveitisPhase 2

Active, not recruiting

Competition

Competitive Landscape

26 competitors in Uveitis

#DrugCompanyPhaseTrials

Humira

Trexall

Jazz Pharmaceuticals

Taltz

Thalomid

Bristol-Myers Squibb

Neoral

Gilenya

Lupkynis

Aurinia Pharmaceuticals

Decadron

AAspen Global Incorporated

Olumiant

Ilevro

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Uveitis1 trial

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema

Active, not recruiting·QQuan Dong Nguyen·Phase 2·NCT05608837·28 enrolled

Cataract1 trial

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Completed·OOculis·Phase 3·NCT05147233·241 enrolled

Eye Pain1 trial

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery

Terminated·OOculis·Phase 3·NCT06128369·117 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for OCS-01. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — OCS-01 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for OCS-01. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Quan Dong Nguyen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: QQuan Dong Nguyen

Related News